Medical data platform operator JNPMEDI raises $10 mn in Series A funding

Medical data platform operator JNPMEDI Inc. announced on Tuesday that it raised 14 billion won ($10.3 million) in a Series A round. 

Pavilion Capital Fund Holdings Pte., a subsidiary of Singapore’s state investment firm Temasek Holdings, was the lead investor, with participation from Kakao Ventures, Murex Partners, AJU IB Investment Co. and Gentium Partners.

The company announced it will use the fresh injection of funds to finalize its global expansion plans and strengthen its research and development (R&D) department. 

“Our vision is to showcase an all-in-one ecosystem that manages all aspects of digital clinical practices,” the startup’s CEO Jeong Kwun-ho said. 

Founded in 2020, JNPMEDI is the developer and operator of a clinical data management platform. 

Write to Lan Heo at why@hankyung.com
Jee Abbey Lee edited this article.